Form 483

Chartwell Pharmaceuticals Carmel, LLC. Form 483, 2013-12-23

FDA issued a Form 483 to Chartwell Pharmaceuticals Carmel, LLC. on 2013-12-23 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Chartwell Pharmaceuticals Carmel, LLC. · Carmel, United States · Issued December 23, 2013

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

23 Dec 2013
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Paul C Mouris

23 Dec 2013
21 CFR 211.100(a)

Changes to Procedures Not Reviewed, Approved

Cited by Paul C Mouris

23 Dec 2013
21 CFR 211.110(a)

Written in-process control procedures

Cited by Paul C Mouris

23 Dec 2013
21 CFR 211.142(b)

Storage under appropriate conditions

Cited by Paul C Mouris

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.110(a)Cited across public-safe Form 483 observations1x
21 CFR 211.142(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere